SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (1065)12/13/1996 3:51:00 AM
From: paul goldstein   of 4342
 
robin, you have stated the obvious. we , collectively are
doing great. i let you folks tell me what the company
announced and i see it better.
as a red neck, let me ask a few thoughts.
if a person with aids took this drug..got , about a 38%
decrease, even if one patient got a 83% decline
in the hiv-1virus in the body while another reported
a 90% increase in the cd4 cell count..then could it mean
that using our product and the cocktails, you have a
better chance?
also, if the other drugs had no affect on our product usage.
then a person would take them both, or all of them
next thought.. what if we increase the dosge strenth/
to me the point was, does it do anything or is it nothing?
it works to a degree..to me that means it can be inproved.
increasing the cd 4 cell count..good for other ills?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News